Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients Patients with ≥1 prior line of therapy were randomized 1:1 to isatuximab ...

In the FlowLine Bipore Heparin vascular prosthesis, heparin is attached to the lumen surface of the prosthesis by means of covalent bondings and ionic interactions, a stable and permanent method ...

“Our subcutaneous clinical program is rooted in our mission to address patient needs and reduce treatment burden in multiple myeloma. We believe the novel on-body injector represents a significant ...

Quaid sued one of heparin's manufacturers last year after his children's overdose was traced to a hospital pharmacy worker who grabbed vials of the wrong dosage because the labels looked almost ...

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and ...

The Final Q-Sub Guidance provides comprehensive guidance on the Q-Sub process and finalizes the draft guidance regarding the Q-Sub program that was issued on March 15, 2024, with minimal changes ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

That’s why it comes with a built-in mixing ball and dry electrolyte-balanced heparin, helping you obtain a clot-free, homogeneous sample and results you can trust. The built-in mixing ball in ...

In a recent study 32 volunteers were injected with 4.5 ml of both buffered and unbuffered lidocaine in the subcutaneous fat of the abdomen (1). Altogether 20 of them stated that the buffered solution ...